Brugmann University Hospital
brugmann.beTotal trials
117
Active
11
Phase 3
5
Total enrollment
52,361
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 5 of 5 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Methadone Hydrochloride | — | — | — | — | — | 1 | |
| Sufentanil Citrate | — | — | — | — | — | 1 | |
| Psilocybin | — | — | — | — | — | 1 | |
| Active placebo | — | — | — | — | — | 1 | |
| Propofol | — | — | — | 3 |
Next readouts
- 2025-12
- 2025-12-15
- 2026-12-31
Top conditions
- Sarcopenia5
- Covid194
- Sickle Cell Disease4
- Breast Cancer3
- Pediatric Cardiac Surgery3
- Cardiac Surgery3
- Multiple Sclerosis3
- Surgery3
Frequently asked questions about Brugmann University Hospital
- How many clinical trials does Brugmann University Hospital have on ClinicalTrials.gov?
- Brugmann University Hospital is listed as the lead sponsor on 117 clinical trials in ClinicalTrials.gov, 11 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Brugmann University Hospital's trials are in Phase 3?
- 5 of Brugmann University Hospital's trials are in Phase 3, spread across 5 active drug programs.
- What therapeutic areas does Brugmann University Hospital focus on?
- Brugmann University Hospital's most-studied conditions on ClinicalTrials.gov are Sarcopenia, Covid19, Sickle Cell Disease, Breast Cancer, Pediatric Cardiac Surgery.
- When are Brugmann University Hospital's next clinical trial readouts?
- Brugmann University Hospital has 3 upcoming primary-completion readouts tracked here; the soonest is “Intraoperative Methadone for the Prevention of Postoperative Pain”, expected around 2025-12.